These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7839243)

  • 1. Sabril--a new antiepileptic agent.
    S Afr Med J; 1994 Oct; 84(10):33, 38. PubMed ID: 7839243
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vigabatrin in the treatment of pediatric epileptic syndrome].
    Lahat E
    Harefuah; 1995 Mar; 128(5):306-8. PubMed ID: 7744355
    [No Abstract]   [Full Text] [Related]  

  • 3. Vigabatrin.
    Calli J; Farrington E
    Pediatr Nurs; 1998; 24(4):357-61. PubMed ID: 9849270
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vigabatrin symposium within the congress "Epilepsy Europe", 3 September 1992, Glasgow].
    Nervenarzt; 1992 Dec; 63(12 Suppl):1-12. PubMed ID: 7477593
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
    De Romanis F; Sopranzi N
    Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Some new problems in the pharmacologic treatment of epilepsy].
    Trabka W; Bacia T
    Pol Tyg Lek; 1994 Jan 24-31; 49(4-5):118-21. PubMed ID: 8029138
    [No Abstract]   [Full Text] [Related]  

  • 8. Vigabatrin.
    Mumford JP; Cannon DJ
    Epilepsia; 1994; 35 Suppl 5():S25-8. PubMed ID: 8039466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new antiepileptic drugs.
    Macleod S; Appleton RE
    Arch Dis Child Educ Pract Ed; 2007 Dec; 92(6):182-8. PubMed ID: 18032714
    [No Abstract]   [Full Text] [Related]  

  • 10. Vigabatrin causes profound reduction in serum alanine transaminase activity.
    Ryan MF; Samy A; Young J
    Ann Clin Biochem; 1996 May; 33 ( Pt 3)():257-8. PubMed ID: 8791991
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal hepatotoxicity in a child treated with vigabatrin.
    Kellermann K; Soditt V; Rambeck B; Klinge O
    Acta Neurol Scand; 1996 May; 93(5):380-1. PubMed ID: 8800351
    [No Abstract]   [Full Text] [Related]  

  • 12. Visual field constriction in children treated with vigabatrin.
    Vanhatalo S; Pääkkönen L; Nousiainen I
    Neurology; 1999 May; 52(8):1713-4. PubMed ID: 10331710
    [No Abstract]   [Full Text] [Related]  

  • 13. Aminoaciduria resulting from vigabatrin administration in children with epilepsy.
    Lahat E; Ben-Zeev B; Zlotnik J; Sela BA
    Pediatr Neurol; 1999 Jul; 21(1):460-3. PubMed ID: 10428431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New drugs in the treatment of childhood epilepsy: vigabatrin (study of 61 subjects)].
    Raucci U; Spalice A; Basile LA; Guardalà C; Nasta L; Terenzi S; Iannetti P
    Pediatr Med Chir; 1994; 16(6):575-8. PubMed ID: 7708543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new anti-epileptic drugs.
    Murphy R
    Ir Med J; 1995; 88(6):198-9. PubMed ID: 8575915
    [No Abstract]   [Full Text] [Related]  

  • 16. Cognitive effects of vigabatrin: a review.
    Monaco F
    Neurology; 1996 Jul; 47(1 Suppl 1):S6-11. PubMed ID: 8677033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril).
    Lambert MV; Bird JM
    Seizure; 1997 Jun; 6(3):233-5. PubMed ID: 9203253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin in childhood epilepsy: a 5-year follow-up study.
    Uldall P; Alving J; Gram L; Høgenhaven H
    Neuropediatrics; 1995 Oct; 26(5):253-6. PubMed ID: 8552215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbed metabolism of guanidino compounds characterized by elevated excretion of beta-guanidinopropionic acid and gamma-guanidinobutyric acid--an effect of vigabatrin treatment?
    Schulze A; Mayatepek E; Frank S; Marescau B; De Deyn PP; Bachert P
    J Inherit Metab Dis; 1998 Jun; 21(3):268-71. PubMed ID: 9686372
    [No Abstract]   [Full Text] [Related]  

  • 20. The economic effects of introducing vigabatrin, a new antiepileptic medication.
    Reinharz D; Kennedy W; Contandriopoulos AP; Tessier G; Champagne F
    Pharmacoeconomics; 1995 Nov; 8(5):400-9. PubMed ID: 10160074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.